Unearthing the Mold: An Investigation of Hospital-Associated Mold Infections in a Medical Intensive Care Unit
Description
COVID-19 associated pulmonary aspergillosis (CAPA) has been frequently described in ICU patients with risk attributed to structural lung injury and immunosuppression. Immunosuppressive therapies including steroids and interleukin-6 receptor